Straumann Holding AG
SAUHF
Market Cap$20.25B
Close$
Earnings Call Q4 2024
February 19, 2025 - AI Summary
Strong Financial Performance: Straumann Group reported an organic revenue growth of 13.7% in 2024, reaching CHF2.5 billion, despite geopolitical tensions and macroeconomic uncertainties. The fourth quarter also performed well with CHF645 million in revenue and 11.5% organic growth.
Regional Growth Dynamics: The EMEA region showed robust double-digit organic revenue growth of 12.3%, while Asia-Pacific emerged as the fastest-growing region with a remarkable 33.3% growth rate. North America, expected to improve in 2025, saw initial signs of stabilization in patient demand towards the end of 2024.
Innovation and Product Launches: The launch of the next-generation iEXCEL implant system has been positively received by clinicians, and the company aims to drive growth through innovations across its premium and challenger brands. Continuous investments in digital solutions and educational initiatives are prioritizing enhancement of clinical outcomes.
Exclusive for Stockcircle Pro members
Sign up
$65.56
52.7% downside
Current Fair Value
52.7% downsideOvervalued by 52.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.25 Billion |
|---|---|
| Enterprise Value | $20.40 Billion |
| Dividend Yield | $1.16384 (0.8886810102899909%) |
| Earnings per Share | $2.44 |
| Beta | 1.33 |
| Outstanding Shares | 137,947,387 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 44.08 |
|---|---|
| PEG | 368.82 |
| Price to Sales | 4.08 |
| Price to Book Ratio | 9.9 |
| Enterprise Value to Revenue | 4.23 |
| Enterprise Value to EBIT | 21.66 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Straumann Holding AG
CEO: Guillaume Daniellot Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Europe, Sales Distributor & Emerging ...